Chinese Journal of Clinical Pharmacology and Therapeutics ›› 1998, Vol. 3 ›› Issue (1): 48-51.
Previous Articles Next Articles
Received:
1998-02-16
Online:
1998-03-26
Published:
2020-12-04
CLC Number:
1 Maitra I, Marcocci L, DroyLef aix MT, et al.Peroxylradial scavenging activity of Ginkg obiloba extract EGB761.Biochem pharmacol, 1995;49(11): 1649 2 Rong Y, Geng Z, Lau BH, et al.Ginkgo biloba at-tenuates oxidative stre ss in macrophages and en-do thelial cells.Free Radic Biol Med, 1996;20(1):121 3 Kose K, Dogan P.Lipope roxidation induced by hy-drog en peroxide in human erythrocy temembr ane s.1. Protective effect of Ginkg obilobaextract (BGB 761).J Int Med Res, 1995;2 3(1):1 4 Kose K, Dog an P.Lipope roxidation induced by hy-dr og an per oxide in humenery thro cyte membrane s.2. Comparison of the antioxidant effect of Ginkgo bilobaextract (EGB 761)with those of wate r-soluble and lipid soluble antioxidants.J Int Med Res, 1995;23 (1):9 5 Tosaki A, Pali T, DroyLefai M T, et al.effects of Ginkgo biloba extract and preconditioning on the diabeticrat my ocardium.Diabe tologia, 1996;39(11): 1255 6 TosakiA, Engelman DT, Pali T, et al.Ginkgo biloba extract (EGB 761)improves postischemic funtion in iso lated preconditioned working rat hearts.Coron Artery Dis, 1994;5(5):4 43 7 Shen JG, Zhou DY.Efficiency of gikgobiloba extract (EGB 761)in antioxidant protection against my ocardial ischemia and reperfusion injury.Biochem Mol Bil Int, 1995;3 5(1):1 25 8 Renesto P, Vicart P, Paulin D, et al.Protective effect of platelet activating factor antag onist on cul-turedendo the lial cell lysis induced by elastase or activated neutrophils.Br J Pharmacol, 1996;117(5): 902 9 So lo viev A, Braquet P.The similarity in action of hypoxia and platelet-activating factor on smooth muscle cells of coronary arteries possible explana tion for hypo xiccorona ry spasm deve lepment.Agent Actions Suppl, 1995;4 5:275 10 Montrucchio G, Allooatti G Tet a C, et al.Release of plateletactivating factor from ischemia-reperfused rabbit heart.Am J Physiol, 1989;2 56:H1236 11 Salinas P.Pere x MP, Fernandez-Sanpablo R, et al.Lack of platet activ ating factor release on acute my ocail ischemia in the isolated interv enticular sep-tum of rabbit hear t, Eur J Pha rmaco l, 1995;2 93 (1):65 12 Chopra K, Singh M, Gupta S, et al.Invovement of oxy gen free radicals in the a ction of bn 52021 (PAF antag onist)to limitmy ocail infart size.Methods Find Exp Clin Pharmacool, 1993;1 5(7):4 37 13 Qian C, Guo ZM, Pete rs CJ, et al.Platelet-a ctiv-ating factor (PAF)induced cardiopulmona ry dys-functions and their reversal with a PAF antag onist (BN52021)in strain 13 guinea pig s.J Lipid Mediat, 1993;7(3):233 14 De-Kimpe SJ, Thiemermann C, Vane JR, et al.Role for int racellular platelet a ctivating factor in the cir-culatory failure in a model of gram-positive shock. Br J Pharmacol, 1995;16(8):3 191 15 Arthur JF, Shahin S, Dusting GT, et al.PAF an-tag onist blo cks induction of nitricoxide synthase in cultur ed macrophages and vascular smooth cells.Clin Exp Pha rmacol Physiol, 1995;2 2(6~7):452 16 Punkt K, Welt K, Schaffraniet L, et al.C hanges of enzyme activaties in the rat myocardium caused by expe rimentak hypoxia with and without ginkg obilo-ba extract EGB 761 pretreatment.A cy tophotome trical study.Acta Histochem, 1995;9 7(1):67 17 Fitzl G, Welt K, Schaffr anietz L, et al.My ocardium-protective effects of ginkg obiloba extract (EGB 761) in old rats against acute isobaric hypoxia.An elec-tron micro scopic morphometriic study.1.Protection of cardiomy ocytes.Exp Tosicol Patthol, 1996;48 (1):33 18 Haramaki N, Ag garwal S, Kaw abata T, et al. effects of natrural antioxidant Ginkg obiloba extract (EGB 761)on my ocardial ischemia reper fusion in jury.Free Radic Biol Med, 1994;16(6):7 89 19 Maruyama M, Farber NE, Ver cellot ti GM, et al. Evidence for a role of platelet activating factor in the pat hogenesis of irre ver sible but not reve rsible my ocardial injury affter reper fusion in dog s.Am Heart J, 1990;1 20(3):510 20 Koltai P, To saki A, Hosford D, et al.Ginkgo lide B protectsiso lated he arts against arry thmias induced by ischemia but ntreper fusion, Eur J Pharmacol, 1989; 164:2 93 21 Lo HM, Lin FY, Tseng CD, et al.effect of EGB 761 aginkg obiloba extract.On e arly a rrhy t hmia induced by coo ronary occlusion and reperf usion in dogs.J Formos Med Assoc, 1994;93(7):5 92 22 Welt K, Fitzl G, Schaff ranietz L, et al.My ocardi-umprotective effects of Ginkgo biloba extract (EGB 761)in old rats against acuteisbaric hypox ia.An electr on micro scopic morphometric study.Ⅱ.Protection of microv ascularendothelium.Exp Toxicl Poathol, 1996;48(1):81 23 Janssens D, Michiels C, Delaive E, et al.Protection of hypox iainduced ATP decr ease in endo thelial ce lls by ginkgo biloba extract and biloba lide.Biochem Pharmacol, 1995;50(7):991 24 Stucher O Pons C, Duverger JP.Effects of ginkg obiloba extract (EGB 761)on arteriolar spasm in a rat cremaser muscle preperation.Int J Micr ocirc Clin EXP, 1996;16(2):98 25 Chan WP, Levy JV.effects of antiplatelet agents on platelet aggregation induced by platelet-activating factor (PAF)in human whole blood.Prostag landins, 1991 26 Patrano C, Cibaattoni G, Puglie se F, et al.Clinical pharmacology of platelet cyclooxy genase iinhibition. Circulation, 1985;72,1177 27 Belougne E, Aguejouf O, Imbault P, Experimental thrombo sis model induced by laser beam.Appliica-tion of aspir in and an extract of Ginkg obiloba:EGB 761.Thromb Res, 1996:82(5):4 53 28 Yan LJ, Droy LM T, Packer L, Ginkgo biloba extract (EGB 761) Protectcs human low density lipoproteins against oxidative modification mediated by copper.Biochem Biophys Res Commun, 1995; 212(2):3 60 |
[1] | LI Yanyang, WANG Yunjiao, LV Shichao. Effects and mechanism of traditional Chinese medicine injection in prevention and treatment of cardiotoxicity induced by antineoplastic drugs [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 572-577. |
[2] | YU Tianyi, JIAO Guangyang, HUANG Doudou, CHEN Yong, XU Deduo, QIU Shi, CHEN Wansheng, ZHANG Feng, WANG Bolong. Analysis of the effective components and mechanism of Yufang Fangji II for prevention of COVID-19 based on UHPLC-Q-TOF/MS and network pharmacology [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1127-1145. |
[3] | YIN Yujie, CHANG Liping. Pharmacological research and clinical applications progress of Lianhua Qingwen capsules/granules in respiratory diseases [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1174-1180. |
[4] | LIU Yunfan, DU Yuemei, LIU Xiaoyi, GAO Liping. Effects of lycium barbarum polysaccharides on cis-dichlorodiamineplatinum (II)-induced apoptosis in mouse testis sertoli cells TM4#br# [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 624-630. |
[5] | LU Yubao, CHEN Yutong, HE Gege, CAI Zongyan, CHENG Yue, CHENG Zihua, GUO Jiamin, GUO Yanzhi. Application of traditional Chinese medicine extract in repairing spinal cord injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 1075-1080. |
[6] | SHI Yin, RUAN Fan, ZHENG Ying. Safety and efficacy of Guizhi Fuling capsule in improving postoperative pregnancy outcome in patients with mild endometriosis infertility [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(12): 1392-1396. |
[7] | YAN Tao, ZHOU Qi-xin, FEI Hui-zhi, HU Xiao-ya, YANG Qiu-jun. A Meta-analysis for hemorrheologic parameters in patients with cerebral infarction or high risk population treated by Shuxuetong or Danshen [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(3): 302-307. |
[8] | LIU Lin-na, WANG Ru-tao, WANG Qing-wei, ZHANG Yan. Effects of Glycyrrhiza uralensis decoction on liver cytochrome P450 in rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(12): 1330-1333. |
[9] | XIE Rui-fang, ZHOU Xin. Research progress on traditional Chinese medicine affecting the metabolism of cytochrome P450 [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(6): 697-700. |
[10] | GUO Yan, WANG Jun, CHEN Zheng-tang. Recent advancement in pharmacological effects of artemisinin and its derivatives [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(6): 615-620. |
[11] | LU Si-jing, LIU You-ning, WANG Hua-zhou. Study of Salvia miltiorrhiza on bleomycin-induced pulmonary fibrosis in mice [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(5): 514-517. |
[12] | LIU Shen-Lin, XIONG Ning-Ning, LIU Fang, WANG Xiu-Qin, GAO Wei-Min. Ethic review on adverse reaction of compound prescription of cnidium fruit in clinical trail [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(2): 238-240. |
[13] | XING Ji-Ping, BAO Ju-Tai, LI Zhi-Tian, SUN Guo, ZHANG Rui-Hong, WANG Shuang-Min. Clinical evaluation of antitoxin cachet for coxsackie B myocarditis in treatment ofPatients with viral myocarditis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(6): 701-703. |
[14] | YUAN Guang-Ping. Evaluation of Efficacy of Astragalus injection in treatment ofPatients with chronic heart failure [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(6): 710-711. |
[15] | XIONG Ning-Ning, LUO Mei, JIANG Meng, LIU Fang, ZHOU Jian-Dong, FU Wei-Min. Design of indicated syndrome and its efficacy evaluation in clinical trial of TCM [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(6): 715-717. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||